相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Metallic Nanoparticles: A New Frontier in the Fight Against Leishmaniasis
Rhanoica Oliveira Guerra et al.
CURRENT MEDICINAL CHEMISTRY (2022)
Thermal shift assays of marine-derived fungal metabolites from Aspergillus fischeri MMERU 23 against Leishmania major pteridine reductase 1 and molecular dynamics studies
Harol R. Arias Cardona et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2022)
Multitarget, Selective Compound Design Yields Potent Inhibitors of a Kinetoplastid Pteridine Reductase 1
Ina Poehner et al.
JOURNAL OF MEDICINAL CHEMISTRY (2022)
Sesquiterpene Lactones with Dual Inhibitory Activity against the Trypanosoma brucei Pteridine Reductase 1 and Dihydrofolate Reductase
Katharina Possart et al.
MOLECULES (2022)
Selection of antileishmanial sesquiterpene lactones from SistematX database using a combined ligand-/structure-based virtual screening approach
Chonny Herrera-Acevedo et al.
MOLECULAR DIVERSITY (2021)
Exploring the ability of dihydropyrimidine-5-carboxamide and 5-benzyl-2,4-diaminopyrimidine-based analogues for the selective inhibition of L. major dihydrofolate reductase
Maria Bibi et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)
Could AlphaFold revolutionize chemical therapeutics?
Alexander B. Tong et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2021)
A resource for improved predictions of Trypanosoma and Leishmania protein three- dimensional structure
Richard John Wheeler
PLOS ONE (2021)
OnionNet-2: A Convolutional Neural Network Model for Predicting Protein-Ligand Binding Affinity Based on Residue-Atom Contacting Shells
Zechen Wang et al.
FRONTIERS IN CHEMISTRY (2021)
SANCDB: an update on South African natural compounds and their readily available analogs
Bakary N'tji Diallo et al.
JOURNAL OF CHEMINFORMATICS (2021)
Identification of Kaurane-Type Diterpenes as Inhibitors of Leishmania Pteridine Reductase I
Chonny Herrera-Acevedo et al.
MOLECULES (2021)
An Overview on Target-Based Drug Design against Kinetoplastid Protozoan Infections: Human African Trypanosomiasis, Chagas Disease and Leishmaniases
Violeta Kourbeli et al.
MOLECULES (2021)
Highly accurate protein structure prediction with AlphaFold
John Jumper et al.
NATURE (2021)
What does AlphaFold mean for drug discovery?
Asher Mullard
NATURE REVIEWS DRUG DISCOVERY (2021)
Accurate prediction of protein structures and interactions using a three-track neural network
Minkyung Baek et al.
SCIENCE (2021)
Nano-Medicines a Hope for Chagas Disease!
Satabdi Datta Choudhury
FRONTIERS IN MOLECULAR BIOSCIENCES (2021)
Recent Developments in Free Energy Calculations for Drug Discovery
Edward King et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2021)
Evidence of Pyrimethamine and Cycloguanil Analogues as Dual Inhibitors of Trypanosoma brucei Pteridine Reductase and Dihydrofolate Reductase
Giusy Tassone et al.
PHARMACEUTICALS (2021)
Identification of Selective Inhibitors of LdDHFR Enzyme Using Pharmacoinformatic Methods
Vishnu Kumar Sharma et al.
JOURNAL OF COMPUTATIONAL BIOLOGY (2021)
Natural Products: Key Prototypes to Drug Discovery against Neglected Diseases Caused by Trypanosomatids
Marina Themoteo Varela et al.
CURRENT MEDICINAL CHEMISTRY (2020)
Identification of a 2,4-diaminopyrimidine scaffold targeting Trypanosoma brucei pteridine reductase 1 from the LIBRA compound library screening campaign
Pasquale Linciano et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
Computational approaches for drug discovery against trypanosomatid-caused diseases
Claudio A. Pereira et al.
PARASITOLOGY (2020)
High-resolution crystal structure of Trypanosoma brucei pteridine reductase 1 in complex with an innovative tricyclic-based inhibitor
Giacomo Landi et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2020)
Nanotechnological interventions for treatment of trypanosomiasis in humans and animals
Kedar Prayag et al.
DRUG DELIVERY AND TRANSLATIONAL RESEARCH (2020)
Chagas Disease: Epidemiology and Barriers to Treatment
Roger M. Mills
AMERICAN JOURNAL OF MEDICINE (2020)
Design, synthesis, and in vitro biological evaluation of novel thiazolopyrimidine derivatives as antileishmanial compounds
Huseyin Istanbullu et al.
ARCHIV DER PHARMAZIE (2020)
Computational Drug Repositioning for Chagas Disease Using Protein-Ligand Interaction Profiling
Alfredo Juarez-Saldivar et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Recent progress in molecular simulation methods for drug binding kinetics
Ariane Nunes-Alves et al.
CURRENT OPINION IN STRUCTURAL BIOLOGY (2020)
Insights into the Control and Management of Human and Bovine African Trypanosomiasis in Zambia between 2009 and 2019-A Review
Gloria M. Mulenga et al.
TROPICAL MEDICINE AND INFECTIOUS DISEASE (2020)
Enhancement of Benzothiazoles as Pteridine Reductase-1 Inhibitors for the Treatment of Trypanosomatidic Infections
Pasquale Linciano et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
DHFR Inhibitors: Reading the Past for Discovering Novel Anticancer Agents
Maria Valeria Raimondi et al.
MOLECULES (2019)
Allostery in Its Many Disguises: From Theory to Applications
Shoshana J. Wodak et al.
STRUCTURE (2019)
Accelerating Drug Discovery Efforts for Trypanosomatidic Infections Using an Integrated Transnational Academic Drug Discovery Platform
Carolina B. Moraes et al.
SLAS DISCOVERY (2019)
Structural Insights into the Development of Cycloguanil Derivatives as Trypanosoma brucei Pteridine-Reductase-1 Inhibitors
Giacomo Landi et al.
ACS INFECTIOUS DISEASES (2019)
An Overview of Drug Resistance in Protozoal Diseases
Rita Capela et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Structure based designing of benzimidazole/benzoxazole derivatives as anti-leishmanial agents
S. Kapil et al.
SAR AND QSAR IN ENVIRONMENTAL RESEARCH (2019)
Identification of Novel Potential Inhibitors of Pteridine Reductase 1 in Trypanosoma brucei via Computational Structure-Based Approaches and in Vitro Inhibition Assays
Magambo Phillip Kimuda et al.
MOLECULES (2019)
ChEMBL: towards direct deposition of bioassay data
David Mendez et al.
NUCLEIC ACIDS RESEARCH (2019)
Expression of a specific variant surface glycoprotein has a major impact on suramin sensitivity and endocytosis in Trypanosoma brucei
Natalie Wiedemar et al.
FASEB BIOADVANCES (2019)
Drug targets for resistant malaria: Historic to future perspectives
Sahil Kumar et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
Characterizing hydration sites in protein-ligand complexes towards the design of novel ligands
Hans Matter et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2018)
Modern Approaches for the Discovery of Anti-Infectious Drugs for the Treatment of Neglected Diseases
Carolina L. Bellera et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2018)
Ionic Liquid-Assisted Extraction and Isolation of Cynaropicrin and Cnicin from Artichoke and Blessed thistle
Hitomi Mizuno et al.
CHEMISTRYSELECT (2018)
Structure-Based Drug Design Strategies and Challenges
Xin Wang et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2018)
Binding Affinity via Docking: Fact and Fiction
Tatu Pantsar et al.
MOLECULES (2018)
Host dihydrofolate reductase (DHFR)-directed cycloguanil analogues endowed with activity against influenza virus and respiratory syncytial virus
Michele Tonelli et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)
Application of a simple quantum chemical approach to ligand fragment scoring for Trypanosoma brucei pteridine reductase 1 inhibition
Wiktoria Jedwabny et al.
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2017)
The Roles of Water in the Protein Matrix: A Largely Untapped Resource for Drug Discovery
Francesca Spyrakis et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
Chroman-4-One Derivatives Targeting Pteridine Reductase 1 and Showing Anti-Parasitic Activity
Flavio Di Pisa et al.
MOLECULES (2017)
In Silico Identification and In Vitro Evaluation of Natural Inhibitors of Leishmania major Pteridine Reductase I
Fabian C. Herrmann et al.
MOLECULES (2017)
Anti-trypanosomatid drug discovery: an ongoing challenge and a continuing need
Mark C. Field et al.
NATURE REVIEWS MICROBIOLOGY (2017)
TRAPP webserver: predicting protein binding site flexibility and detecting transient binding pockets
Antonia Stank et al.
NUCLEIC ACIDS RESEARCH (2017)
Comparative mapping of on-targets and off-targets for the discovery of anti-trypanosomatid folate pathway inhibitors
Joanna Panecka-Hofman et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2017)
Exploiting the 2-Amino-1,3,4-thiadiazole Scaffold To Inhibit Trypanosoma brucei Pteridine Reductase in Support of Early-Stage Drug Discovery
Pasquale Linciano et al.
ACS OMEGA (2017)
Profiling of Flavonol Derivatives for the Development of Antitrypanosomatidic Drugs
Chiara Borsari et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Escaping Deleterious Immune Response in Their Hosts: Lessons from Trypanosomatids
Anne Geiger et al.
FRONTIERS IN IMMUNOLOGY (2016)
ChEMBL web services: streamlining access to drug discovery data and utilities
Mark Davies et al.
NUCLEIC ACIDS RESEARCH (2015)
Challenges facing the elimination of sleeping sickness in west and central Africa: sustainable control of animal trypanosomiasis as an indispensable approach to achieve the goal
Gustave Simo et al.
PARASITES & VECTORS (2015)
SANCDB: a South African natural compound database
Rowan Hatherley et al.
JOURNAL OF CHEMINFORMATICS (2015)
Stakeholder Narratives on Trypanosomiasis, Their Effect on Policy and the Scope for One Health
Catherine Grant et al.
PLOS NEGLECTED TROPICAL DISEASES (2015)
Escape mechanisms of African trypanosomes: why trypanosomosis is keeping us awake
Jennifer Cnops et al.
PARASITOLOGY (2015)
Antiprotozoal Activity Profiling of Approved Drugs: A Starting Point toward Drug Repositioning
Marcel Kaiser et al.
PLOS ONE (2015)
Targeting Bacterial Central Metabolism for Drug Development
Paul Murima et al.
CHEMISTRY & BIOLOGY (2014)
Structure-Based Design and Synthesis of Antiparasitic Pyrrolopyrimidines Targeting Pteridine Reductase 1
Abedawn I. Khalaf et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Challenges towards the elimination of Human African Trypanosomiasis in the sleeping sickness focus of Campo in southern Cameroon
Gustave Simo et al.
PARASITES & VECTORS (2014)
Epidemiology of human African trypanosomiasis
Jose R. Franco et al.
CLINICAL EPIDEMIOLOGY (2014)
Nifurtimox-Eflornithine Combination Therapy for Second-Stage Gambiense Human African Trypanosomiasis: Medecins Sans Frontieres Experience in the Democratic Republic of the Congo
Emilie Alirol et al.
CLINICAL INFECTIOUS DISEASES (2013)
Biochemical effects of riluzole on Leishmania parasites
Davide Guerrieri et al.
EXPERIMENTAL PARASITOLOGY (2013)
Principles and Applications of Halogen Bonding in Medicinal Chemistry and Chemical Biology
Rainer Wilcken et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Drug resistance in African trypanosomiasis: the melarsoprol and pentamidine story
Nicola Baker et al.
TRENDS IN PARASITOLOGY (2013)
Mosaic VSGs and the Scale of Trypanosoma brucei Antigenic Variation
James P. J. Hall et al.
PLOS PATHOGENS (2013)
Miltefosine: a review of its pharmacology and therapeutic efficacy in the treatment of leishmaniasis
Thomas P. C. Dorlo et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)
ZINC: A Free Tool to Discover Chemistry for Biology
John J. Irwin et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2012)
Structure-Based Selectivity Optimization of Piperidine-Pteridine Derivatives as Potent Leishmania Pteridine Reductase Inhibitors
Paola Corona et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Trypanosomal Dihydrofolate Reductase Reveals Natural Antifolate Resistance
Jarunee Vanichtanankul et al.
ACS CHEMICAL BIOLOGY (2011)
Design, Synthesis and Biological Evaluation of Novel Inhibitors of Trypanosoma brucei Pteridine Reductase 1
Daniel Spinks et al.
CHEMMEDCHEM (2011)
Folate metabolic pathways in Leishmania
Tim J. Vickers et al.
ESSAYS IN BIOCHEMISTRY: MOLECULAR PARASITOLOGY (2011)
Dissecting the Metabolic Roles of Pteridine Reductase 1 in Trypanosoma brucei and Leishmania major
Han B. Ong et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Virtual Screening Identification of Nonfolate Compounds, Including a CNS Drug, as Antiparasitic Agents Inhibiting Pteridine Reductase
Stefania Ferrari et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
High-resolution structures of Trypanosoma brucei pteridine reductase ligand complexes inform on the placement of new molecular entities in the active site of a potential drug target
Alice Dawson et al.
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY (2010)
Synthesis and characterization of potent inhibitors of Trypanosoma cruzi dihydrofolate reductase
Norbert Schormann et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2010)
Structure-Based Design of Pteridine Reductase Inhibitors Targeting African Sleeping Sickness and the Leishmaniases
Lindsay B. Tulloch et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Trypanosoma brucei pteridine reductase 1 is essential for survival in vitro and for virulence in mice
Natasha Sienkiewicz et al.
MOLECULAR MICROBIOLOGY (2010)
Structures of dihydrofolate reductase-thymidylate synthase of Trypanosoma cruzi in the folate-free state and in complex with two antifolate drugs, trimetrexate and methotrexate
Olga Senkovich et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2009)
One Scaffold, Three Binding Modes: Novel and Selective Pteridine Reductase 1 Inhibitors Derived from Fragment Hits Discovered by Virtual Screening
Chidochangu P. Mpamhanga et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Probing the Flexibility of Large Conformational Changes in Protein Structures through Local Perturbations
Bosco K. Ho et al.
PLOS COMPUTATIONAL BIOLOGY (2009)
Discovery of potent pteridine reductase inhibitors to guide antiparasite drug development
Antonio Cavazzuti et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Structure-based approach to pharmacophore identification, in silico screening, and three-dimensional quantitative structure-activity relationship studies for inhibitors of Trypanosoma cruzi dihydrofolate reductase function
N. Schormann et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2008)
Extra precision glide: Docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes
Richard A. Friesner et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Structure and reactivity of Trypanosoma brucei pteridine reductase:: inhibition by the archetypal antifolate methotrexate
Alice Dawson et al.
MOLECULAR MICROBIOLOGY (2006)
Lipophilic antifolate trimetrexate is a potent inhibitor of Trypanosoma cruzi:: Prospect for chemotherapy of Chagas' disease
O Senkovich et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Inhibitors of dihydrofolate reductase in leishmania and trypanosomes
IH Gilbert
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2002)
Pteridine reductase mechanism correlates pterin metabolism with drug resistance in trypanosomatid parasites
DG Gourley et al.
NATURE STRUCTURAL BIOLOGY (2001)
分享论文
